Ownership history in BARCLAYS PLC · 19 quarters on record
This page tracks every 13F SEC filing in which BARCLAYS PLC reported a position in SOLENO THERAPEUTICS INC (SLNO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 157,685 | +129,285 | +455.2% | 0.00% | $7.3M | $46.30 |
| 2025 Q3 | REDUCED | 28,400 | -21,600 | -43.2% | 0.00% | $1.9M | $67.60 |
| 2025 Q3 | REDUCED | 50,000 | -120,980 | -70.8% | 0.00% | $3.4M | $67.60 |
| 2025 Q3 | ADDED | 170,980 | +32,565 | +23.5% | 0.00% | $11.6M | $67.60 |
As of 2025 Q4 — sorted by position size